Fordham Law alumna Min Wang ’03 has been appointed chief legal and administrative officer at BlueRock Therapeutics, LP, an engineered cell therapy company.
In her new role, Dr. Wang will join the company’s Executive team, and hold broad management responsibility for all legal aspects of the business, including intellectual property, contracts, financial and corporate governance and risk management, as well as management of administrative functions at the company.
…
Dr. Wang brings more than 20 years of senior leadership and legal experience in the biotechnology industry. She was most recently Senior Vice President, General Counsel and Corporate Secretary at Agios Pharmaceuticals Inc., from its inception through the IPO process and as a public company traded on NASDAQ. During her tenure, Agios grew to nearly 500 employees, raised $1.5 billion in public market funding and signed numerous co-development deals with industry partners. Prior to Agios, Dr. Wang served as Senior Patent Counsel at Genentech and Merck where she managed a wide range of therapeutic portfolios in oncology, immunology and antifungal products and negotiated research partnerships. Prior to Merck, Dr. Wang was employed in the law firm of Fish & Neave in their Intellectual Property group. Dr. Wang received her Ph.D. in organic chemistry from Brown University and her J.D. from the Fordham University School of Law.
